Antigens comprising immunostimulant adjuvants and their use in i

Details Antigens comprising immunostimulant adjuvants and their use in i Antigens comprising immunostimulant adjuvants and their use in i

1979-11-13

1981-08-25

Phillips, Delbert R.

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Genetically modified micro-organism, cell, or virus

424 88, A61K 3910, A61K 3900

Patent

active

042859301

ABSTRACT:
Antigens are provided which induce relatively large titers of antibodies. These antigens, which may comprise certain strains of microorganisms or a plant extract, can be conjugated to a second antigen by means of an organic coupling agent. The primary antigens of the invention, when chemically coupled to a secondary antigen function as immunostimulant adjuvants. When tumor cells are the secondary antigens, a means for immunotherapeutic treatment of cancer is provided.

REFERENCES:
Likhite, V. V., "Clinical Cancer Immunotherapy: Experience in Breast and Lung Cancer", Immunocancerology in Solid Tumors, (Martin, M. and Dionne, L., eds.), pp. 135-141, 1976.
Likhite, V. V., IRCS Medical Science, 4,565, (1976).

Affiliated with

Also associated with

Rating

Antigens comprising immunostimulant adjuvants and their use in i does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antigens comprising immunostimulant adjuvants and their use in i, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antigens comprising immunostimulant adjuvants and their use in i will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1158270